Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ACMSD | Q8TDX5 | 2/20 | 0.41 |
| ▸ | RARB | P10826 | 3/20 | 0.41 |
| ▸ | RARA | P10276 | 2/20 | 0.41 |
| ▸ | RARG | P13631 | 1/20 | 0.41 |
| ▸ | CFB | P00751 | 1/20 | 0.39 |
| ▸ | DHODH | Q02127 | 4/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.38 |
| ▸ | ACLY | P53396 | 1/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.37 |
| ▸ | RXRB | P28702 | 1/20 | 0.37 |
| ▸ | RXRG | P48443 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7736071 | 1.00 | CYP2C9 (0.53) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| Hydrochloric Acid SCHEMBL8066406 | 0.99 | CYP2C9 (0.52) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| Hydrochloric Acid SCHEMBL8066411 | 0.99 | CYP2C9 (0.52) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL9827929 | 0.99 | CYP2C9 (0.52) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL10524705 | 0.99 | CYP2C9 (0.52) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL10782844 | 0.96 | CYP2C9 (0.50) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL10782847 | 0.96 | CYP2C9 (0.50) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL7028128 | 0.96 | CYP2C9 (0.50) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL8387294 | 0.96 | CYP2C9 (0.50) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL8104563 | 0.91 | RARB (0.47) | CYP2C9ALDH1A1LMNAMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10584284-B2 | Antioxidant having difluoromethoxy group, liquid crystal composition, and liquid crystal display device | JNC CORPORATION (JP) | 2020-03-10 | — | — | US | disclosed |
| US-20160130501-A1 | ANTIOXIDANT HAVING DIFLUOROMETHOXY GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2016-05-12 | — | — | US | disclosed |
| CN-102199139-B | Liquid crystalline cpd and liquid crystal media | MERCK PATENT GMBH (DE) | 2016-01-27 | — | — | CN | disclosed |
| US-6468606-B1 | LOW VISCOSITY, HIGH DIELECTRIC ANISOTROPY, LOW OPTICAL ANISOTROPY, EXCELLENT LOW TEMPERATURE COMPATIBILITY WITH OTHER LIQUID CRYSTALLINE COMPOUNDS; 3,4,5-TRIFLUOROPHENYL-(2-FLUORO-4-(TRANS-4-PROPYLCYCLOHEXYL))BENZOATE | CHISSO CORPORATION (JP) | 2002-10-22 | — | — | US | disclosed |
| EP-0808825-B1 | PHENYL BENZOATE DERIVATIVES AND LIQUID CRYSTAL COMPOSITIONS | CHISSO CORP (JP) | 2001-09-12 | — | — | EP | disclosed |
| EP-0808886-B1 | LIQUID CRYSTAL COMPOSITIONS AND LIQUID CRYSTAL DISPLAY ELEMENTS | CHISSO CORP (JP) | 2000-08-23 | — | — | EP | disclosed |
| US-5922243-A | LOW VISCOSITY, HIGH DIELECTRIC AND LOW OPTICAL ANISOTROPY, EXCELLENT COMPATIBILITY | CHISSO CORPORATION (JP) | 1999-07-13 | — | — | US | disclosed |
| US-5855814-A | Liquid crystal compositions and liquid crystal display elements | CHISSO CORPORATION (JP) | 1999-01-05 | — | — | US | disclosed |
| EP-0808886-A1 | LIQUID CRYSTAL COMPOSITIONS AND LIQUID CRYSTAL DISPLAY ELEMENTS | CHISSO CORPORATION (JP) | 1997-11-26 | — | — | EP | disclosed |
| EP-0808825-A1 | PHENYL BENZOATE DERIVATIVES AND LIQUID CRYSTAL COMPOSITIONS | CHISSO CORPORATION (JP) | 1997-11-26 | — | — | EP | disclosed |
| EP-0446911-A1 | Fluorobenzene derivatives | MERCK PATENT GmbH (DE) | 1991-09-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160130501-A1 | ANTIOXIDANT HAVING DIFLUOROMETHOXY GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | GPX1, LPO, GPX4 | CYP2C9 1286/4885ALDH1A1 51/4885LMNA 3041/4885 |
| US-10584284-B2 | Antioxidant having difluoromethoxy group, liquid crystal composition, and liquid crystal display device | GPX1, LPO, GSTO1 | CYP2C9 1251/4885ALDH1A1 144/4885LMNA 3306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.